HYTN Innovations receives first order from SNDL Inc., expanding into global cannabis markets.

HYTN Innovations Inc., a cannabis pharmaceutical company, received its first purchase order from SNDL Inc., a major global cannabis firm. This partnership will use EU Good Manufacturing Practice standards to process cannabis products for international markets, including the UK, Germany, and Australia. The move aims to scale operations and capitalize on the growing global cannabis market, valued at billions.

January 11, 2025
4 Articles